Agenus Inc is an American clinical-phase firm with a pipeline of therapies built to activate the body’s immune process to fight cancer and bacterial infections, together with immune-modulatory antibodies, adoptive mobile therapies as a result of its subsidiary MiNK Therapeutics Inc. and vaccin